Home > Animal Health & Nutrition > Veterinary Services > Veterinary Assistive Reproduction Technology Market

Veterinary Assistive Reproduction Technology Market Share

Report ID: GMI10258
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Veterinary Assistive Reproduction Technology Market Share

The competitive landscape in the market is characterized by a mix of established players and emerging innovators, each striving to carve out a niche in this rapidly evolving sector. Technological advancements such as in vitro fertilization (IVF), embryo transfer techniques, and genetic screening tools have spurred competition, driving companies to differentiate through efficacy, cost-effectiveness, and the ability to cater to diverse animal species. Moreover, partnerships with veterinary hospitals, research collaborations, and strategic acquisitions are common strategies employed to expand market presence and enhance technological capabilities in this dynamic field.

Veterinary Assistive Reproduction Technology Market Companies

Prominent players operating in the veterinary assistive reproduction technology industry include:

Bovine Elite, LLC
CRV Holdings B.V.
Geno SA
Genus Plc
Minitube Group
SEMEX
Select Sires, Inc.
Swine Genetics International
STgenetics
URUS Group LP
VikingGenetics

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Veterinary assistive reproduction technology industry size was USD 6.8 billion in 2023 and is projected to expand at 6.8% CAGR from 2024 to 2032, due to the rising demand for high-value livestock and pets.

The services type segment in the veterinary assistive reproduction technology industry accounted for USD 2.9 billion in 2023 owing to the increasing demand for specialized reproductive services.

The artificial insemination technology segment in the veterinary assistive reproduction technology industry accounted for 71.5% share in 2023 as it offers significant advantages in genetic improvement, disease control, and reproduction management across various animal species.

North America veterinary assistive reproduction technology accounted for 38.6% share in 2023 and is projected to expand at 6.5% CAGR between 2024 and 2032, due to the presence of advanced veterinary healthcare infrastructure and a strong focus on animal welfare.